10-Q Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001759655-23-000211`
Period End Date	20230930
Filing Date	20231103
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	prva-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 76 Cash Flow Statement 66 Stockholders Equity 44

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	114.69M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$330.39M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$347.99M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	118.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$189.60M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$350.11M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	118.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.37M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.17M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$697.67M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$551.96M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.60M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.39M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$7.10M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$8.09M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$107.24M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$57.39M	USD	Point-in-time
Goodwill	`Goodwill`	$135.61M	USD	Point-in-time
Goodwill	`Goodwill`	$126.94M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$35.19M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$40.37M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.68M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$6.92M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$294.66M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$240.85M	USD	Point-in-time
Total assets	`Assets`	$992.33M	USD	Point-in-time
Total assets	`Assets`	$792.81M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$54.33M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$52.84M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$208.42M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$336.64M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$3.01M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$3.23M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$394.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$264.27M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$5.77M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$8.49M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.00M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.31M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$9.49M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$7.08M	USD	Point-in-time
Total liabilities	`Liabilities`	$273.76M	USD	Point-in-time
Total liabilities	`Liabilities`	$401.27M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 118,004,544 and 114,690,808 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$1.18M	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 118,004,544 and 114,690,808 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$1.15M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$739.95M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$714.64M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-216.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-196.45M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$544.68M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$499.09M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$19.95M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$46.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$591.06M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$556.52M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$571.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$491.07M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$992.33M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$792.81M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$342.90M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$992.24M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$417.28M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.22B	USD	3 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$325.22M	USD	1 Quarter
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$949.20M	USD	3 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$265.17M	USD	1 Quarter
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$766.67M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$50.32M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$127.50M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$145.25M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$43.84M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$5.09M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$18.48M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$7.24M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$14.57M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$101.44M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$27.23M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$79.99M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$32.22M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.73M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.15M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.76M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.44M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$411.75M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.01B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.20B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$347.47M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$19.23M	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-4.57M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-21.37M	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$5.54M	USD	1 Quarter
Interest (income) expense, net	`InterestIncomeExpenseNet`	$285.00K	USD	1 Quarter
Interest (income) expense, net	`InterestIncomeExpenseNet`	$2.89M	USD	1 Quarter
Interest (income) expense, net	`InterestIncomeExpenseNet`	$5.52M	USD	3 Qtrs
Interest (income) expense, net	`InterestIncomeExpenseNet`	$-610.00K	USD	3 Qtrs
Income (loss) before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.29M	USD	1 Quarter
Income (loss) before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-21.98M	USD	3 Qtrs
Income (loss) before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.43M	USD	1 Quarter
Income (loss) before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$24.75M	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$6.93M	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-4.84M	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$6.05M	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$2.49M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$18.70M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$6.40M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$556.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.94M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.36M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-28.91M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-18.09M	USD	1 Quarter
Gain (loss) attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$299.00K	USD	1 Quarter
Gain (loss) attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.55M	USD	3 Qtrs
Gain (loss) attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.07M	USD	1 Quarter
Gain (loss) attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.54M	USD	3 Qtrs
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$1.62M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$5.64M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$20.24M	USD	3 Qtrs
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-26.36M	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.24	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.05	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.17	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.05	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.16	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.24	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	117.60M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	111.59M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	109.46M	shares	3 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	116.27M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.65M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	109.46M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.85M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.92M	shares	1 Quarter

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$18.70M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$6.40M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$556.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.94M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.36M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-28.91M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-18.09M	USD	1 Quarter
Depreciation	`Depreciation`	$927.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$878.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$2.51M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$3.88M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$800.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.40M	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	-	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$687.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$58.18M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$25.43M	USD	3 Qtrs
Deferred tax expense	`DeferredIncomeTaxExpenseBenefit`	$5.18M	USD	3 Qtrs
Deferred tax expense	`DeferredIncomeTaxExpenseBenefit`	$6.55M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$128.95M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$156.22M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.66M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.80M	USD	3 Qtrs
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$7.71M	USD	3 Qtrs
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$1.25M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$1.49M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$1.27M	USD	3 Qtrs
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$113.57M	USD	3 Qtrs
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$123.93M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.75M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.51M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-32.00K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.68M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.04M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$89.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$90.00K	USD	3 Qtrs
Business Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Business Acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$37.86M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-37.95M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-89.00K	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$33.25M	USD	3 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$11.49M	USD	3 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$8.79M	USD	3 Qtrs
Repurchase of non-controlling interest	`PaymentsToMinorityShareholders`	$5.69M	USD	3 Qtrs
Repurchase of non-controlling interest	`PaymentsToMinorityShareholders`	-	USD	3 Qtrs
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	$125.00K	USD	3 Qtrs
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	$569.00K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.66M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-21.63M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.68M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-17.60M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$347.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$330.39M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$316.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$347.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$330.39M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$316.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$40.00K	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$680.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.02M	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$266.00K	USD	3 Qtrs

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	118.00M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$591.06M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$556.52M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$571.31M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$491.07M	USD	Point-in-time
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.00M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$799.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.31M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.48M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$8.57M	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.12M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.38M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.47M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$24.88M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.83M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.25M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.80M	USD	1 Quarter
Repurchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$5.69M	USD	1 Quarter
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$569.00K	USD	1 Quarter
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$125.00K	USD	1 Quarter
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$24.21M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$18.70M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$6.40M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$556.00K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$5.94M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$6.36M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-28.91M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-18.09M	USD	1 Quarter
Ending balance (in shares)	`CommonStockSharesOutstanding`	118.00M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	114.69M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$519.05M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$591.06M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$556.52M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$571.31M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$491.07M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.